H

Hamilton Allergy | Hamilton, Canada

Research site

(Unclaimed)

Location

201-1685 Main St W, Hamilton, Ontario, Canada

Site insights

Top conditions

Top treatments

LY3454738

Upadacitinib

Dupilumab

Povorcitinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 8 total trials

Status recently updated

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis (Start Up)

Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Topical therapies applied over the skin...

Enrolling

Active, not recruiting

Atopic Dermatitis

Drug: Upadacitinib

Drug: Dupilumab

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma

The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function

Active, not recruiting

Moderate to Severe Asthma

Drug: ICS-LABA

Other: placebo

Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)

The primary objective of this study is to assess the 6-month safety of DBV712 250 micrograms (mcg) in subjects 1 through 3 years of age with peanut a...

Active, not recruiting

Peanut Allergy

Allergy

Combination Product: DBV712 250 mcg

Combination Product: Placebo